Top 50 Companies in Genetic Engineering Market Worldwide 2025: Market Research Report (2024–2035)

Description

According to a research report published by Spherical Insights & Consulting, The Global Genetic Engineering Market Size is projected to Grow from USD 1.63 Billion in 2024 to USD 13.23 Billion by 2035, at a CAGR of 20.97% during the forecast period 2025-2035. The market for genetic engineering is in greater demand as it is being revolutionised by advances in gene-editing technologies, especially CRISPR and other precision tools, which make it possible to modify DNA with extreme accuracy and affordability. This breakthrough supports growing applications in synthetic biology, sustainable agriculture, such as climate-resilient crops, and precision medicine. The market is expanding due to the rising demand for biopharmaceuticals and the rising incidence of genetic diseases.

 

Introduction

Genetic engineering, referred to as genetic modification, is the process of manipulating an organism's DNA in a lab to add, remove, or change genes to produce desired characteristics. Genetic engineering, referred to as genetic modification, is a laboratory-based process that modifies an organism's DNA to produce desired traits. This could entail moving genes between species as well as adding, removing, or altering single base pairs or DNA segments. Genetic engineering is widely used in biotechnology, agriculture, and medicine. It has made it possible to create industrial uses such as engineered yeast strains, genetically modified crops and livestock, and cancer treatments. The growing use of CRISPR genome editing technology and the growing need for synthetic genes are the main factors propelling market expansion. Developments in gene therapy and rising public and private funding are other factors driving expansion. Intellia Therapeutics' successful Phase 1 clinical trial findings for their CRISPR-based ATTR amyloidosis treatment were a noteworthy breakthrough. With few adverse effects, the treatment dramatically lowered target protein levels, underscoring the increasing efficacy and clinical significance of CRISPR-based treatments in human health.

 

Navigate Future Markets with Confidence: Insights from Spherical Insights LLP

The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.

 

Unlock exclusive market insights-Download the Brochure now and dive deeper into the future of the Genetic Engineering Market.

 

Genetic Engineering Market Size & Statistics

• The Market Size for Genetic Engineering Was Estimated to be worth USD 1.63 Billion in 2024.
• The Market Size is Going to Expand at a CAGR of 20.97% between 2025 and 2035.
• The Global Genetic Engineering Market Size is anticipated to reach USD 13.23 Billion by 2035.
• North America is expected to generate the highest demand during the forecast period in the Genetic Engineering Market
• Asia Pacific is expected to grow the fastest during the forecast period in the Genetic Engineering Market.

Regional growth and demand

Asia Pacific is expected to grow the fastest during the forecast period in the genetic engineering market. The market for genetic engineering is now growing in the Asia Pacific due to government-sponsored precision medicine programs, expanding healthcare infrastructure, and growing demand for biotechnology products. With its emphasis on precision medicine and the existence of significant biotech companies like BGI and Hebei Senlang Biotechnology, China is driving the region's growth.

 

North America is expected to generate the highest demand during the forecast period in the genetic engineering market. The genetic engineering market with the quickest rate of growth throughout the study period is anticipated to be in North America, because of its robust biotech sector, substantial R&D facilities, and kind regulatory frameworks. Advancements in gene therapy, precision medicine, and genetically modified crops are fuelled by the United States' consistent government support, particularly large NIH funding, and a talented pool of researchers. The sector in Canada is also growing due to cooperative research projects and genomics-focused initiatives run by groups like Genome Canada. North America's leading position is cemented, and sustained market expansion is guaranteed by this mix of investment, innovation, and regulatory backing.

 

Top 10 trends in the Genetic Engineering Market

• CRISPR-Based Gene Editing Goes Mainstream
• Rise of Personalized Medicine
• Synthetic Biology Driving Innovation
• Convergence with AI and Data Analytics
• Expansion in Agricultural Biotechnology
• Emerging Role of Bio-Manufacturing
• Surge in Clinical Gene Therapy Trials
• Ethical, Regulatory, and IP Challenges
• De-Extinction & Conservation Genetics
• Enabling Technologies & Next-Gen Toolkits

 

1. CRISPR-Based Gene Editing Goes Mainstream

CRISPR-based gene editing is making the leap from research labs to practical uses in industry and medicine. Clinical progress is quickening; the first CRISPR treatment for sickle cell disease, Casgevy, was approved by the FDA and other countries, bringing gene editing into the mainstream of medicine. Advances in technology, such as improved CRISPR systems like base and prime editors, have increased precision while decreasing off-target effects, increasing the medicinal and research uses of CRISPR. As a result of its increasing maturity, CRISPR is becoming a vital tool for curing genetic illnesses, enhancing human health, and speeding up research in many fields.

 

2. Rise of Personalized Medicine

Precision medicine, referred to as personalised medicine, is revolutionising healthcare by customising treatments for each patient according to their environment, lifestyle, and genetic profile. Particularly in fields like oncology and rare diseases, technological innovations like companion diagnostics, AI-driven data analysis, and reasonably priced genomic sequencing allow for more precise targeting and fewer negative consequences. Multi-omics techniques and liquid biopsies are examples of innovative tools that further enhance illness identification and treatment personalisation. Healthcare is moving towards proactive, preventive treatment as genomic data is incorporated into clinical systems, improving patient outcomes and redefining therapeutic approaches to be more flexible and customised.

 

3. Synthetic Biology Driving Innovation

Applications of synthetic biology are developing quickly in a variety of fields, including automated biofoundries, AI-powered design, sustainable materials, and more effective biomanufacturing pipelines. Researchers are increasingly using cell-free platforms, automated biofoundries, and AI-guided genetic circuits to speed up the design-build-test cycle, cutting down on development time and enhancing scalability. Engineering microorganisms for enhanced carbon capture, bioplastics, and biodegradable materials using materials inspired by nature, such as spider silk proteins are example of sustainable impacts. Bio-based alternatives to traditional production in textiles, building, and agriculture provide a strong, sustainable innovation ecosystem, while AI integration improves predictive modelling, biosafety, and regulatory compliance.

 

4. Convergence with AI and Data Analytics

Genetic engineering is undergoing a revolution thanks to the use of artificial intelligence and data analytics, which speed up discovery, improve precision, and streamline processes. These days, AI-powered models find the best Cas9 variations and CRISPR guide RNA sequences, lowering off-target effects and increasing editing accuracy. Machine learning algorithms quickly identify functional patterns in massive genomic datasets, accelerating breakthroughs in protein engineering, therapeutic targeting, and disease detection. This convergence powers advances in biotechnology, agriculture, and personalised medicine by enabling automated, data-driven design and testing cycles in synthetic biology and genetic research.

 

5. Expansion in Agricultural Biotechnology

Agricultural biotechnology is revolutionising farming around the world by making it possible to create sustainable agricultural practices and high-yielding, climate-resilient crops. In response to growing food demand and environmental concerns, advances in genetic engineering and genome editing technologies like CRISPR are producing crop types that are more nutrient-dense, pest-resistant, and drought-tolerant. Bioengineered bacteria that improve soil health and lower the need for chemical fertilisers are among the innovations, as is RNAI-based technology for environmentally friendly insect control. Plant development cycles are accelerated by precision agriculture and AI-driven crop breeding, which further simplifies genetic trait selection. As agriculture looks for more resilient and sustainable methods, these biotechnology developments are leading the way in modernising farming systems across the globe.

 

Empower your strategic planning:

Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the genetic engineering market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.

 

Top 23 Companies Leading the Genetic Engineering Market

1. Thermo Fisher Scientific Inc.
2. Cibus
3. HORIZON DISCOVERY GROUP PLC
4. GenScript Biotech Corporation
5. CRISPR Therapeutics AG
6. Recombinetics Inc.
7. Sangamo
8. MERCK KGAA
9. Precision Biosciences
10. OriGene Technologies Inc.
11. Intellia Therapeutics Inc.
12. Caribou Biosciences Inc.
13. Eurofins Scientific SE
14. Agilent Technologies, Inc.
15. Amgen
16. Sangamo Therapeutics
17. Genentech
18. Transposagen Biopharmaceuticals
19. OriGene Technologies
20. Editas Medicine
21. Cellectis
22. Intellia Therapeutics
23. Bluebird Bio

 

1. Thermo Fisher Scientific Inc.

Headquarters: Massachusetts, USA

A pioneer in the life sciences, diagnostics, and applied markets, Thermo Fisher Scientific Inc. offers scientific equipment, reagents, consumables, software, and services. Through brands like Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services, its extensive offerings, which include analytical instruments, molecular biology tools, clinical diagnostics, and laboratory products, serve pharmaceutical and biotech companies, research institutions, hospitals, and government agencies. Based in Waltham, Massachusetts, USA, Thermo Fisher provides integrated solutions that promote creativity, laboratory productivity, and scientific discovery globally.

 

2. Cibus

Headquarters: California, USA

The business specialises in precision gene-editing technologies that are used to create and license high-throughput trait enhancements for major crops like wheat, soybeans, rice, and canola without introducing foreign DNA. Through its exclusive Rapid Trait Development System and Trait Machine platform, Cibus immediately introduces productivity-boosting traits into superior germplasm, including herbicide tolerance, disease resistance, and reduced pod shattering. Seed businesses subsequently commercialise the licenses under royalty agreements, establishing Cibus as a technology-driven force behind effective, sustainable agricultural solutions.

 

3. HORIZON DISCOVERY GROUP PLC

Headquarters: Cambridge, United Kingdom

Horizon Discovery Group plc, a leading supplier of gene editing and gene modification technologies to the life sciences industry, has its headquarters located in Cambridge, United Kingdom. The company provides a comprehensive library of more than a million gene-edited cell lines and reagent products, which are utilised by university researchers, diagnostic companies, and drug developers to validate therapeutic targets, mimic disease mechanisms, and support personalised medicine initiatives. By precisely altering or modulating almost any gene in human and animal cells, Horizon's products facilitate translational research, drug discovery, and therapeutic development.

 

4. GenScript Biotech Corporation

Headquarters: Jiangsu, China

DNA and peptide synthesis, protein expression systems, antibodies, CRISPR reagents, genome editing tools, and CDMO services for biologics development are just a few of the many life science solutions it provides. Across more than 100 countries, GenScript has extensive client engagement and supports a wide range of applications, including drug development, vaccine research, immunotherapy, and synthetic biology. Cell treatment, industrial synthetic biology, biologics development, and life-science services are all included in its integrated business platforms.

 

5. CRISPR Therapeutics AG

Headquarters: Zug, Switzerland

CRISPR Therapeutics AG is a Swiss-American biotechnology company that uses its own CRISPR gene-editing platform to develop revolutionary gene-based medications. Targeting autoimmune, cardiovascular, oncological, regenerative, and hemoglobinopathies, the company has created a strong portfolio of therapeutic initiatives. Its main treatment, Casgevy exagamglogene autotemcel, is authorised to treat transfusion-dependent beta-thalassemia and sickle cell disease.

 

Are you ready to discover more about the genetic engineering market?

The report provides an in-depth analysis of the leading companies operating in the global genetic engineering market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:

 

Company Profiles

1. Thermo Fisher Scientific Inc.

• Business Overview
• Company Snapshot
• Products Overview
• Company Market Share Analysis
• Company Coverage Portfolio
• Financial Analysis
• Recent Developments
• Merger and Acquisitions
• SWOT Analysis

1. Cibus
2. HORIZON DISCOVERY GROUP PLC
3. GenScript Biotech Corporation
4. CRISPR Therapeutics AG
5. Recombinetics Inc.
6. Sangamo
7. IBM
8. MERCK KGAA
9. Others.

 

Conclusion

The genetic engineering market is accelerating due to the growing as chronic and transmissible diseases become more common. Rapid, accurate detection and treatment of infectious and chronic diseases are made possible by advancements in genome editing and multi-omics. Additionally, genetic engineering speeds up the research of new treatments and improves patient care by streamlining the production of biopharmaceuticals like insulin and vaccinations. As a result, its expanding significance in healthcare supports notable market growth over the course of the projection period.

 

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter